|
|
|
|
|
Indiana
|
|
0-5534
|
|
35-0160330
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|||
111 Congressional Boulevard, Carmel IN |
|
46032
|
||
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
|
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the
Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended
transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
|
||||||
Securities registered pursuant to Section 12(b) of the Act:
|
||||||
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
||||
Class A Common Stock, No Par Value
|
PTVCA
|
The Nasdaq Stock Market LLC
|
||||
Class B Common Stock, No Par Value
|
PTVCB
|
The Nasdaq Stock Market LLC
|
(d) |
Exhibits.
|
● |
Book value per share increased by $0.68 per share to $24.63 during the
first quarter of 2019, an increase of 2.8% in the quarter and total value creation of 3.3% including the $0.10 per share dividend paid to shareholders during the first quarter of 2019.
|
● |
Net investment income increased 34.4% for the first quarter of 2019
compared to the prior year.
|
● |
Combined ratio of 108.0% for the first quarter of 2019, down from
112.2% for the fourth quarter of 2018.
|
● |
Repurchased $3.5 million (197,397 shares) since January 1, 2019.
These purchases are immediately accretive to book value, given an average repurchase price of 72% of March 31, 2019 book value ($3.0 million of the $3.5 million in repurchases occurred after March 31, 2019).
|
5% Increase in Ultimate Loss Ratio
|
10% Increase in Ultimate Loss Ratio
|
|||||||
Gross loss expense from further strengthening current reserve position
|
$
|
35.3
|
$
|
70.7
|
||||
Net financial loss
|
9.2
|
18.1
|
||||||
$/share (after tax)
|
$
|
0.49
|
$
|
0.96
|
Three Months Ended
|
||||||||
March 31
|
||||||||
2019
|
2018
|
|||||||
Income before federal income tax expense (benefit)
|
$
|
3,514
|
$
|
314
|
||||
Less: Net realized gains (losses) on investments
|
(299
|
)
|
376
|
|||||
Less: Net unrealized gains (losses) - equity securities and limited partnerships
|
6,327
|
(4,909
|
)
|
|||||
Income (loss) from core business operations
|
$
|
(2,514
|
)
|
$
|
4,847
|
|||
Less: Net investment income
|
6,232
|
4,636
|
||||||
Underwriting income (loss)
|
$
|
(8,746
|
)
|
$
|
211
|
Unaudited Condensed Consolidated Balance Sheets
|
||||||||
(in thousands, except per share data)
|
||||||||
March 31
|
December 31
|
|||||||
2019
|
2018
|
|||||||
Assets
|
||||||||
Investments 1:
|
||||||||
Fixed income securities (2019:
$669,128; 2018: $600,504)
|
$
|
671,973
|
$
|
592,645
|
||||
Equity securities
|
68,956
|
66,422
|
||||||
Limited partnerships, at equity
|
38,239
|
55,044
|
||||||
Commercial mortgage loans
|
7,844
|
6,672
|
||||||
Short-term 2
|
1,000
|
1,000
|
||||||
788,012
|
721,783
|
|||||||
Cash and cash equivalents
|
117,418
|
163,996
|
||||||
Restricted cash and cash equivalents
|
15,888
|
6,815
|
||||||
Accounts receivable
|
108,974
|
102,972
|
||||||
Reinsurance recoverable
|
404,424
|
392,436
|
||||||
Other assets
|
95,572
|
88,426
|
||||||
Current federal income taxes
|
6,025
|
7,441
|
||||||
Deferred federal income taxes
|
3,478
|
6,262
|
||||||
$
|
1,539,791
|
$
|
1,490,131
|
|||||
Liabilities and shareholders' equity
|
||||||||
Reserves for losses and loss expenses
|
$
|
894,221
|
$
|
865,339
|
||||
Reserves for unearned premiums
|
80,332
|
71,625
|
||||||
Borrowings under line of credit
|
20,000
|
20,000
|
||||||
Accounts payable and other liabilities
|
179,168
|
177,085
|
||||||
1,173,721
|
1,134,049
|
|||||||
Shareholders' equity:
|
||||||||
Common stock-no par value
|
634
|
634
|
||||||
Additional paid-in capital
|
55,049
|
54,720
|
||||||
Accumulated other comprehensive income ( loss)
|
1,416
|
(7,347
|
)
|
|||||
Retained earnings
|
308,971
|
308,075
|
||||||
366,070
|
356,082
|
|||||||
$
|
1,539,791
|
$
|
1,490,131
|
|||||
Number of common and common
|
||||||||
equivalent shares outstanding
|
14,865
|
14,869
|
||||||
Book value per outstanding share
|
$
|
24.63
|
$
|
23.95
|
||||
1 2019 & 2018 cost in parentheses
|
||||||||
2 Approximates cost
|
Unaudited Condensed Consolidated Statements of Operations
|
||||||||
(in thousands, except per share data)
|
||||||||
Three Months Ended
|
||||||||
March 31
|
||||||||
2019
|
2018
|
|||||||
Revenues
|
||||||||
Net premiums earned
|
$
|
110,013
|
$
|
105,462
|
||||
Net investment income
|
6,232
|
4,636
|
||||||
Commissions and other income
|
2,064
|
1,814
|
||||||
Net realized gains (losses) on investments, excluding impairment losses
|
(39
|
)
|
376
|
|||||
Other-than-temporary impairment losses on investments
|
(260
|
)
|
-
|
|||||
Net unrealized gains (losses) on equity securities and limited partnership investments
|
6,327
|
(4,909
|
)
|
|||||
Net realized and unrealized gains (losses) on investments
|
6,028
|
(4,533
|
)
|
|||||
124,337
|
107,379
|
|||||||
Expenses
|
||||||||
Losses and loss expenses incurred
|
87,122
|
72,298
|
||||||
Other operating expenses
|
33,701
|
34,767
|
||||||
120,823
|
107,065
|
|||||||
Income before federal income tax expense (benefit)
|
3,514
|
314
|
||||||
Federal income tax expense (benefit)
|
766
|
(16
|
)
|
|||||
Net income
|
$
|
2,748
|
$
|
330
|
||||
Per share data - diluted:
|
||||||||
Income (loss) before net gains (losses) on investments
|
$
|
(.14
|
)
|
$
|
.22
|
|||
Net gains (losses) on investments
|
.32
|
(.20
|
)
|
|||||
Net income
|
$
|
.18
|
$
|
.02
|
||||
Dividends
|
$
|
.10
|
$
|
.28
|
||||
Reconciliation of shares outstanding:
|
||||||||
Average shares outstanding - basic
|
14,848
|
15,010
|
||||||
Dilutive effect of share equivalents
|
30
|
24
|
||||||
Average shares outstanding - diluted
|
14,878
|
15,034
|
Unaudited Condensed Consolidated Statements of Cash Flows
|
||||||||
(in thousands)
|
||||||||
Three Months Ended
|
||||||||
March 31
|
||||||||
2019
|
2018
|
|||||||
Net cash provided by operating activities
|
$
|
11,405
|
$
|
8,027
|
||||
Investing activities:
|
||||||||
Purchases of available-for-sale investments
|
(140,645
|
)
|
(140,820
|
)
|
||||
Purchases of limited partnership interests
|
-
|
(200
|
)
|
|||||
Proceeds from sales or maturities
|
||||||||
of available-for-sale investments
|
68,975
|
103,657
|
||||||
Proceeds from sales of equity securities
|
9,169
|
59,757
|
||||||
Purchase of insurance company-owned life insurance
|
-
|
(10,000
|
)
|
|||||
Purchase of commercial mortgage loans
|
(1,172
|
)
|
-
|
|||||
Distributions from limited partnerships
|
17,214
|
-
|
||||||
Other investing activities
|
(797
|
)
|
(1,214
|
)
|
||||
Net cash provided by (used in) investing activities
|
(47,256
|
)
|
11,180
|
|||||
Financing activities:
|
||||||||
Dividends paid to shareholders
|
(1,493
|
)
|
(4,229
|
)
|
||||
Repurchase of common shares
|
(468
|
)
|
(235
|
)
|
||||
Net cash used in financing activities
|
(1,961
|
)
|
(4,464
|
)
|
||||
Effect of foreign exchange rates on cash and cash equivalents
|
307
|
(223
|
)
|
|||||
Increase (decrease) in cash, cash equivalents and restricted cash and cash equivalents
|
(37,505
|
)
|
14,520
|
|||||
Cash, cash equivalents and restricted cash and cash equivalents at beginning of period
|
170,811
|
68,713
|
||||||
Cash, cash equivalents and restricted cash and cash equivalents at end of period
|
$
|
133,306
|
$
|
83,233
|
Protective Insurance Corporation and Subsidiaries
|
||||||||
(In thousands, except per share data)
|
Three Months Ended
|
|||||||
March 31
|
||||||||
2019
|
2018
|
|||||||
Annualized
|
||||||||
Book value per share beginning of period
|
$
|
23.95
|
$
|
27.83
|
||||
Book value per share end of period
|
24.63
|
27.38
|
||||||
Change in book value per share
|
$
|
0.68
|
$
|
(0.45
|
)
|
|||
Dividends paid
|
0.10
|
0.28
|
||||||
Change in book value per share plus dividends paid
|
$
|
0.78
|
$
|
(0.17
|
)
|
|||
Total value creation 1
|
13.0
|
%
|
(2.4
|
%)
|
||||
Return on average shareholders' equity:
|
||||||||
Average shareholders' equity
|
361,076
|
415,311
|
||||||
Net income
|
2,748
|
330
|
||||||
Less: Net realized gains (losses) on investments, net of tax
|
4,762
|
(3,581
|
)
|
|||||
Net operating income (loss)
|
(2,014
|
)
|
3,911
|
|||||
Return on net income 2
|
3.0
|
%
|
0.3
|
%
|
||||
Return on net operating income (loss) 2
|
(2.2
|
%)
|
3.8
|
%
|
||||
Loss and LAE expenses incurred
|
$
|
87,122
|
$
|
72,298
|
||||
Net premiums earned
|
110,013
|
105,462
|
||||||
Loss and LAE ratio
|
79.2
|
%
|
68.6
|
%
|
||||
Other operating expenses
|
$
|
33,701
|
$
|
34,767
|
||||
Less: Commissions and other income
|
2,064
|
1,814
|
||||||
Other operating expenses, less commissions and other income
|
$
|
31,637
|
$
|
32,953
|
||||
Net premiums earned
|
110,013
|
105,462
|
||||||
Expense ratio
|
28.8
|
%
|
31.2
|
%
|
||||
Combined ratio 3
|
108.0
|
%
|
99.8
|
%
|
||||
Gross premiums written
|
$
|
148,893
|
$
|
148,823
|
||||
Net premiums written
|
115,322
|
113,434
|
||||||
1 Total Value Creation equals change in book value plus dividends paid, divided by beginning book
value. Quarterly amounts have been annualized.
|
||||||||
2 Quarterly amounts have been annualized
|
||||||||
3 The combined ratio is calculated as ratio of losses and loss expenses incurred, plus other operating
expenses, less commission and other income to net premiums earned.
|
+?"S^(%LK
MJRN_L>J:?+YMK<%=P!XRK#T.!67_ ,(GK^O:O877BN^T][6P?S8K6P1PLCCH
MSEOY=.U$)Q]V3>P3A+WHI;D?QA_Y$";_ *^(OYT[XOR2)\/KD(Q >:)7QW&[
M/\P*WO%_AT>*?#5SI7G"%Y"K1R%